Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Mylan receives FDA approval for generic etodolac

May 22, 1997

Merck updates development of higher dose Zocor

May 21, 1997

SmithKline Beecham's Famvir receives U.K. approval for new indication

May 21, 1997

Gensia receives ANDA approval for etoposide injection

May 21, 1997

Roche seeks FDA approval for new formulation of saquinavir

May 14, 1997

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

May 13, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Update on Interferon Sciences' Alferon N Injection

May 13, 1997

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

FDA approves Mylan's generic extended-release diltiazem

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....